Karyopharm(KPTI)

LAES16802-06 01:29

$Karyopharm(KPTI)$ 逆市飘扬，传被一家大型公司收购。查看全文

LAES16802-01 08:54

$Karyopharm(KPTI)$ 尾盘1️⃣笔50多万砸给了自己人，盘后又收回。看来要启动了查看全文

LAES16801-30 02:56

$Karyopharm(KPTI)$ 上车查看全文

LAES16802-03 04:01

$Karyopharm(KPTI)$ boom查看全文

LAES16802-01 00:32

$Karyopharm(KPTI)$ 静待本月好消息$AXS创新ETF2倍做多(TARK)$查看全文

jesseWarrenSoros02-06 23:10

$Karyopharm(KPTI)$ 重仓調入查看全文

持股变动声明

Karyopharm(KPTI)03-05 08:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025190  Size: 7 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-05 08:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025188  Size: 7 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-01 06:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023281  Size: 4 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-07 05:15

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027153  Size: 5 KB 网页链接查看全文

酒鬼爱花生03-11 12:47

$Karyopharm(KPTI)$ 和德琪医药市值相当，因塞里尼所结缘的两家公司查看全文

jesseWarrenSoros02-06 23:10

$Karyopharm(KPTI)$ 重仓調入查看全文

LAES16802-06 01:29

$Karyopharm(KPTI)$ 逆市飘扬，传被一家大型公司收购。查看全文

LAES16802-03 04:01

$Karyopharm(KPTI)$ boom查看全文

LAES16802-01 08:54

$Karyopharm(KPTI)$ 尾盘1️⃣笔50多万砸给了自己人，盘后又收回。看来要启动了查看全文

LAES16802-01 00:32

$Karyopharm(KPTI)$ 静待本月好消息$AXS创新ETF2倍做多(TARK)$查看全文

LAES16801-30 02:56

$Karyopharm(KPTI)$ 上车查看全文

转出首个上市产品的部分商业化权利，德琪医药意欲何为？

药智网2023-08-24 15:20

来源：药智网公众号
图片来源：摄图网
近日，港股上市公司德琪医药发布公告称，与翰森制药达成独家合作协议，由翰森制药负责塞利尼索在中国大陆的商业化， 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解，塞利尼索是德琪医药首个上市商业化产品，从Karyopharm引进，...查看全文

$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-02-07,Director,Mirza Mansoor Raza ,期权,1500普通股, $0.26

$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-08 AccNo: 0000902219-18-000141 Size: 37 KB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2018-02-07 AccNo: 0001193125-18-034708 Size: 342 KB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-07 AccNo: 0000038777-18-000087 Size: 210 KB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-01 AccNo: 0000215457-18-004631 Size: 13 KB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-26 AccNo: 0001144204-18-004055 Size: 89 KB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-01-26 AccNo: 0001193125-18-021593 Size: 1 MB 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ 8-K - Current report Filed: 2018-01-25 AccNo: 0001193125-18-019721 Size: 24 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

$Karyopharm Therapeutics Inc.(KPTI)$ 8-K - Current report Filed: 2018-01-25 AccNo: 0001193125-18-019000 Size: 51 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Karyopharm Therapeutics Inc.(KPTI)$ 内部交易: 2018-01-18,CEO,Kauffman Michael ,卖出,10000普通股, $10.09